Showing results (321-330 of 426) with videos related to
Sort By:
Pageof 43
Journal of Cardiac Failure|July 4, 2021
Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) TrialRobert J Mentz, Hillary Mulder, Arend Mosterd, et al.Journal of the American College of Cardiology|June 24, 2024
Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF TrialsSubodh Verma, Javed Butler, Barry A Borlaug, et al.Journal of Cardiac Failure|January 12, 2023
Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker SubstudyChristopher R Defilippi, Wendimagegn G Alemayehu, Adriaan A Voors, et al.European Heart Journal|May 2, 2017
Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF)Peter S Pang, Javed Butler, Sean P Collins, et al.Circulation. Heart Failure|October 5, 2014
Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HFPriyesh A Patel, Gretchen Heizer, Christopher M O'Connor, et al.European Journal of Heart Failure|June 30, 2021
Vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction: insights from the VICTORIA trialPiotr Ponikowski, Wendimagegn Alemayehu, Ali Oto, et al.JACC. Heart Failure|February 5, 2015
Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure)G Michael Felker, Javed Butler, Sean P Collins, et al.The New England Journal of Medicine|August 26, 2023
Ferric Carboxymaltose in Heart Failure with Iron DeficiencyRobert J Mentz, Jyotsna Garg, Frank W Rockhold, et al.International Journal of Cardiology|May 4, 2020
Cardiovascular disease burden in adult patients with cancer: An 11-year nationwide population-based cohort studyJong-Chan Youn, Woo-Baek Chung, Justin A Ezekowitz, et al.Journal of the American College of Cardiology|March 26, 2016
Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF StudyJohn R Teerlink, G Michael Felker, John J V McMurray, et al.Pageof 43